Hemostasis in the Era of the Chronic Anticoagulated Patient

Journal of Invasive Cardiology

Volumn 15, Issue 11, 2003, Pages 669-674

  Weiner, Bonnie ^c   Fischer, Thomas ^a   Waxman, Sergio ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c Box 244 ^*

Author keywords

Anticoagulation; Hemostasis; PGlcNAc; Vasoconstriction

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEMOSTATIC AGENT; HEPARIN; N ACETYLGLUCOSAMINE; PLACEBO; POLY N ACETYGLUCOSAMINE; POLY N ACETYL GLUCOSAMINE; POLY-N-ACETYL GLUCOSAMINE; POLYMER; UNCLASSIFIED DRUG;

ANTICOAGULATION; BLEEDING; BLOOD CELL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION THERAPY; CONTINUING EDUCATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEART CATHETERIZATION; HEMAGGLUTINATION; HEMATOMA; HEMOSTASIS; HUMAN; MEDICAL INSTRUMENTATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCANNING ELECTRON MICROSCOPY; SIDE EFFECT; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; VASOCONSTRICTION;

ACETYLGLUCOSAMINE; ANTICOAGULANTS; HEMOSTASIS; HEMOSTATICS; HUMANS;

EID: 0242661944     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. Ikeda Y, Young LH, Vournakis JN, Lefer AM. Vascular effects of poly-N-acetylglucosamine in isolated rat aortic rings. J Surg Res 2002;102:215-220.
2. Hoffer EK, Bloch RD. Percutaneous arterial closure devices. J Vasc Interv Radiol 2003;14:865-885.
3. Najjar SF, Healey N, Healey CM, et al. A blinded randomized trial to evaluate the hemostatic effectiveness of poly-N-acetylglucosamine in patients undergoing cardiac catheterization. Am J Cardiol 2003;92(Suppl): 151L.
4. Hirsch, et al. A clinical protocol to test the use of the Syvek Patch as a technique to effect the closure of the arteriotomy site in interventional neuroradiology. Presented at the American Society of Neuroradiology 39th Annual Meeting, April 23-27, 2001, in Boston, Massachusetts.
5. Shubrooks SJ Jr., Nesto RW, Leeman DE, et al. Earlier ambulation at 2 hours following cardiac catheterization using Syvek Patch. Presented at the SCAI 2000 Meeting in Boston, Massachusetts.
6. Palmer B, Gantt DS, Lawrence ME, et al. One hour bedrest after coronary angiography with 6F catheters, Presented at the SCAI 26th Annual Scientific Meeting, May 7-10, 2003, in Boston, Massachusetts.
7. Nader RG, Garcia JC, Drushal K, Pesek T. Clinical evaluation of the SyvekPatch® in consecutive patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invas Cardiol 2002;14:305-307.